List view / Grid view
In its latest meeting, the Committee for Medicinal Products for Human Use (CHMP) recommended eight new medicines for approval, including an enzyme replacement therapy for a rare disease.
Indivior’s $145 million acquisition of Opiant Pharmaceuticals will support the launch of OPNT003, an opioid overdose reversal agent.
The FDA has approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence...
The FDA has announced its latest action to encourage and support the development of treatment options for people with opioid use disorder...
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
